People · Operator
Named in public records as an officer, director or promoter · active 2021–2025 · Biotech / Pharma, Healthtech, Other Energy, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Alto Pharmacy Holdings, Inc. | — | Biotech / Pharma | Series D+ | $169.7M | $3.1B | 2021 |
| Mendel Health Inc. | — | Healthtech | Series B | $52.7M | $570.9M | 2021 |
| Maverick Labs, Inc. | — | Other Energy | Series B | $15.6M | $91.6M | 2023 |
| Rinascera Therapeutics, Inc. | — | Biotechnology | Seed | $2.5M | $6.2M | 2025 |
Nichola Eliovits at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nichola Eliovits on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ROBERT SPINNER | 1 | 4 |
| Neil Shah | 1 | 4 |
| Kevin Burns | 1 | 4 |
| Kyle Lui | 1 | 3 |
| James Karraker | 1 | 2 |
| Mattieu Gamache-Asselin | 1 | 2 |
| Max Dawson | 1 | 1 |
| Daniel Yadegar | 1 | 1 |
| Karl Beutner | 1 | 1 |
| Wael Salloum | 1 | 1 |
| Karim Galil | 1 | 1 |
| William B. Deitch | 1 | 1 |
| Jesse Evans | 1 | 1 |
| Eric Herrera | 1 | 1 |
| Nathaniel Kan | 1 | 1 |
| Eric Herrara | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.